Collegium Pharmaceutical Incorporated
United StatesFDA applicant, unverified
- Devices
- 3
What Collegium Pharmaceutical Incorporated makes
Collegium Pharmaceutical Incorporated manufactures topical emollient foams and gels designed for skin hydration and wound care, including Hylatopic Emollient Foam, Hylatopic Plus Emollient Foam, and Dryodine Cadexomer-Iodine Gel for managing exudative wounds.
These products are classified as Class II devices under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Hylatopic Emollient Foam Ref K083024
Regimes: 510(k) Registry: 510(k)Dryodine Cadexomer-Iodine Gel Ref K093320
Regimes: 510(k) Registry: 510(k)Hylatopic Plus Emollient Foam Ref K093051
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Collegium Pharmaceutical Incorporated have in the registry?
The registry currently lists 3 devices for Collegium Pharmaceutical Incorporated. Devices recorded under merged duplicate company entries are counted once.
Which registries list Collegium Pharmaceutical Incorporated's devices?
Among its 3 most recently registered devices, Collegium Pharmaceutical Incorporated has devices listed in FDA 510(k) (3 devices).
What are the newest devices from Collegium Pharmaceutical Incorporated in the registry?
The most recently registered devices listed for Collegium Pharmaceutical Incorporated include HYLATOPIC EMOLLIENT FOAM, DRYODINE CADEXOMER-IODINE GEL and HYLATOPIC PLUS EMOLLIENT FOAM.